Autosomal dominant generalized dystrophic epidermolysis bullosa

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:231568OMIM:131750Q81.2
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal dominant generalized dystrophic epidermolysis bullosa (ADDEB-G), also known as autosomal dominant dystrophic epidermolysis bullosa generalisata, is a hereditary skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) group. It is caused by heterozygous mutations in the COL7A1 gene, which encodes type VII collagen, a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in skin blistering and erosions following minor mechanical trauma. The condition typically presents at birth or in early infancy with widespread (generalized) blistering of the skin. Key clinical features include skin fragility with blisters and erosions that heal with scarring, milia (small white cysts) formation, and dystrophic or absent nails. The blistering can affect the trunk, extremities, and sometimes mucosal surfaces including the oral cavity and esophagus, though mucosal involvement is generally less severe than in recessive forms of dystrophic EB. Over time, patients may develop hypertrophic or atrophic scarring. Compared to autosomal recessive dystrophic epidermolysis bullosa, the autosomal dominant generalized form tends to have a milder clinical course, though significant variability exists even within families carrying the same mutation. There is currently no cure for ADDEB-G. Management is primarily supportive and focuses on wound care, prevention of trauma and infection, pain management, and nutritional support. Careful wound dressing with non-adherent bandages is essential. Monitoring for complications such as esophageal strictures, dental abnormalities, and secondary skin infections is important. Emerging therapies including gene therapy, protein replacement therapy, and cell-based approaches are under investigation but remain largely experimental. Genetic counseling is recommended for affected individuals and their families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Dystrophic toenailHP:0001810Acral blisteringHP:0031045Absent toenailHP:0001802Absent fingernailHP:0001817Recurrent loss of toenails and fingernailsHP:0008390Dystrophic fingernailsHP:0008391Erosion of oral mucosaHP:0031446
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal dominant generalized dystrophic epidermolysis bullosa.

View clinical trials →

No actively recruiting trials found for Autosomal dominant generalized dystrophic epidermolysis bullosa at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal dominant generalized dystrophic epidermolysis bullosa community →

No specialists are currently listed for Autosomal dominant generalized dystrophic epidermolysis bullosa.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal dominant generalized dystrophic epidermolysis bullosa.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal dominant generalized dystrophic epidermolysis bullosaForum →

No community posts yet. Be the first to share your experience with Autosomal dominant generalized dystrophic epidermolysis bullosa.

Start the conversation →

Latest news about Autosomal dominant generalized dystrophic epidermolysis bullosa

No recent news articles for Autosomal dominant generalized dystrophic epidermolysis bullosa.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Autosomal dominant generalized dystrophic epidermolysis bullosa

What is Autosomal dominant generalized dystrophic epidermolysis bullosa?

Autosomal dominant generalized dystrophic epidermolysis bullosa (ADDEB-G), also known as autosomal dominant dystrophic epidermolysis bullosa generalisata, is a hereditary skin fragility disorder belonging to the dystrophic epidermolysis bullosa (DEB) group. It is caused by heterozygous mutations in the COL7A1 gene, which encodes type VII collagen, a critical structural protein that forms anchoring fibrils at the dermal-epidermal junction. Deficiency or dysfunction of type VII collagen leads to impaired adhesion between the epidermis and dermis, resulting in skin blistering and erosions followi

How is Autosomal dominant generalized dystrophic epidermolysis bullosa inherited?

Autosomal dominant generalized dystrophic epidermolysis bullosa follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal dominant generalized dystrophic epidermolysis bullosa typically begin?

Typical onset of Autosomal dominant generalized dystrophic epidermolysis bullosa is neonatal. Age of onset can vary across affected individuals.